◇ Promotion
▲ Jang In-geun, President of HLB Bio Strategic Planning Headquarters ▲ Kang Hee-beom, Director (Executive Director) of New Drug Research Institute, R&D Bio Business Headquarters, HLB Life Sciences
◇ Transfer and Dispatch
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Greater Impact on Women Than Men"... The 'Diet Trap' That Causes Sleepless Nights and Suffering
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
▲ Baek Yoon-gi, CEO (President) of HLB ▲ Kim Dong-gun, Head of HLB USA Corporation ▲ Kim Ki-hwan, Vice President, Head of HLB Bio Strategic Planning Headquarters
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
